Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/202410:17AMBusiness WireFinance in Motion und Napier AI arbeiten gemeinsam an AML für sichere Impact Investments
04/24/202410:17AMPR Newswire (Canada)REMBRANDT - Gravures du Museum Boijmans Van Beuningen - Un grand maître de l'art hollandais à l'honneur à Québec!
04/24/202410:16AMGlobeNewswire Inc.Fly Play hf.: Increase of share capital
04/24/202410:16AMBusiness WireFinance in Motion et Napier AI s'associent pour la lutte contre le blanchiment d'argent afin de sécuriser les investissements à impact.
04/24/202410:15AMBusiness WireLynk Announces Sat2Phone Contract with U.S. Government
04/24/202410:15AMPR Newswire (US)Seven Bleakley Financial Group Advisors Named Among Forbes Best-in-State 2024 List
04/24/202410:15AMPR Newswire (US)CCNY's Keith Gandal discovers link between increased stress, fatal car crashes and blue states during pandemic
04/24/202410:15AMPR Newswire (US)Nature's Sunshine's Impact Report Highlights Achievements and Continued Commitment Toward SustainabilityNASDAQ:NATRNatures Sunshine Products Inc
04/24/202410:15AMPR Newswire (US)Veterinary Innovation Council Launches New Resources to Help Provide Access to Veterinary Care to Millions of Pet Owners in Underserved Communities
04/24/202410:15AMPR Newswire (US)Top Luxury Day Spa Burke Williams Announces 2024 Plans, Massage Industry Trends
04/24/202410:15AMPR Newswire (US)Conversational AI Market worth $49.9 billion by 2030 - Exclusive Report by MarketsandMarkets™
04/24/202410:15AMPR Newswire (US)Sapience Therapeutics Announces Oral Presentation at the Upcoming 2024 ASCO Annual Meeting Featuring ST101 Phase 2 Results in GBM
04/24/202410:15AMPR Newswire (US)Conversational AI Market worth $49.9 billion by 2030 - Exclusive Report by MarketsandMarkets™
04/24/202410:14AMPR Newswire (US)Health researchers can now use SAS to analyze one of the world's most diverse biomedical data sets
04/24/202410:13AMBusiness WireT-Mobile Unveils BIG Moves to Help Small Businesses GrowNASDAQ:TMUST Mobile US Inc
04/24/202410:13AMPR Newswire (US)Hitachi Astemo Has Received the General Motors 2023 Overdrive Award
04/24/202410:11AMGlobeNewswire Inc.Fulcrum GT Renews Its Commitment to Els for Autism Foundation
04/24/202410:11AMGlobeNewswire Inc.Crédit Mutuel Home Loan SFH - Communiqué de mise à disposition du Rapport financier annuel 2023
04/24/202410:10AMGlobeNewswire Inc.Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
04/24/202410:10AMBusiness WireHilton Grand Vacations Unveils 2024 Brand Ambassadors to Headline Exclusive Member ExperiencesNYSE:HGVHilton Grand Vacations Inc
04/24/202410:10AMBusiness WireSheppard Mullin Welcomes IP Partner Alex Chung in Washington D.C.
04/24/202410:10AMPR Newswire (US)Global Distribution Transformer Market to Reach $47.5 billion, Globally, by 2033 at 6.6% CAGR: Allied Market Research
04/24/202410:10AMPR Newswire (US)Global Distribution Transformer Market to Reach $47.5 billion, Globally, by 2033 at 6.6% CAGR: Allied Market Research
04/24/202410:10AMPR Newswire (US)Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
04/24/202410:10AMBusiness WireNature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
04/24/202410:09AMGlobeNewswire Inc.Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024NASDAQ:CGEMCullinan Therapeutics Inc
04/24/202410:08AMGlobeNewswire Inc.Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Gated Waterfront Living Experience in Freeport, New York
04/24/202410:07AMPR Newswire (US)American Association of Critical-care Nurses Publishes Specialty's First Standards for Appropriate Staffing
04/24/202410:07AMPR Newswire (US)GRAINGER INCREASES QUARTERLY DIVIDEND BY 10%; REFRESHES SHARE REPURCHASE AUTHORIZATIONNYSE:GWWWW Grainger Inc
04/24/202410:05AMGlobeNewswire Inc.Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCONASDAQ:REGNRegeneron Pharmaceuticals Inc